PAF1 and liver cancer: We found that similar to the positive drug 5-FU, PD2 significantly decreased the viability of liver cancer cells; however, unlike 5-FU, PD2 had no obvious inhibitory effect on normal liver cells (Fig. 1A and Table 1).